Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-001312
Filing Date
2025-01-10
Accepted
2025-01-10 18:16:27
Documents
1
Period of Report
2025-01-09

Document Format Files

Seq Description Document Type Size
1 form4-01102025_110123.html 4  
1 form4-01102025_110123.xml 4 3915
  Complete submission text file 0001415889-25-001312.txt   5377
Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Issuer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FIBROGEN, INC. 350 BAY STREET, SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address
DeLucia David (Reporting) CIK: 0002040705 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36740 | Film No.: 25524245